5-(4-Fluorophenyl)-5-oxopentanoic Acid: PPAR Activator Intermediate
Dissolution Kinetics in Polar Aprotic vs Non-Polar Solvents & Technical Specifications for Late-Stage Amide Coupling
When scaling late-stage amide coupling protocols for fluorinated keto-acids, solvent selection dictates both reaction velocity and byproduct profile. 5-(4-Fluorophenyl)-5-oxopentanoic acid exhibits distinct solvation behavior depending on the dielectric constant of the medium. In polar aprotic systems such as DMF, NMP, or DMSO, the carboxylic acid moiety forms stable hydrogen-bonded networks that accelerate carbodiimide or uronium salt activation. Conversely, in non-polar media like toluene or heptane, dissolution requires elevated temperatures or co-solvent assistance, which can introduce thermal degradation risks if not carefully monitored. At NINGBO INNO PHARMCHEM CO.,LTD., we engineer our material to function as a direct drop-in replacement for legacy supplier batches, ensuring identical kinetic profiles while improving supply chain reliability and cost-efficiency.
Field data from pilot-scale runs indicates that trace moisture in polar aprotic solvents can hydrolyze activated esters before nucleophilic attack, shifting equilibrium toward N-acylurea byproducts. We recommend rigorous solvent drying and inert atmosphere maintenance during the coupling phase. For teams optimizing their synthesis route, maintaining a consistent solvent-to-substrate ratio prevents localized concentration gradients that commonly cause yield drop-offs in multi-kilogram batches. Our material is processed to pharmaceutical grade standards, ensuring predictable solvation shells and reproducible coupling rates across different reactor geometries.
Micronized Particle Size Distribution Control & Bulk Packaging Protocols for Reaction Homogeneity
Reaction homogeneity in heterogeneous or semi-heterogeneous coupling systems is directly tied to particle size distribution. Micronized grades of this intermediate reduce the diffusion layer thickness around solid particles, accelerating dissolution and minimizing localized supersaturation. When particle size varies significantly between batches, feed rates become inconsistent, leading to exothermic spikes or incomplete conversion. We control D50 and D90 parameters through precision milling and sieving, ensuring uniform flow characteristics for automated dosing systems.
Bulk packaging protocols are designed to preserve physical integrity during transit. Standard shipments utilize 210L steel drums or IBC totes with multi-layer polyethylene liners to prevent moisture ingress and mechanical degradation. A critical field consideration involves winter logistics: during sub-zero transit, the carboxylic acid chain can undergo partial surface crystallization due to localized cooling. Operators should allow a 24-hour ambient equilibration period before opening containers. This controlled warming prevents clumping and ensures consistent feed rates during reactor charging. Physical packaging specifications and handling guidelines are detailed in our shipping documentation, focusing strictly on mechanical stability and transit safety.
COA Parameters & Purity Grades Preventing Trace Chloride/Fluoride Catalyst Poisoning in Palladium Systems
Trace halide impurities are a primary cause of catalyst deactivation in palladium-mediated cross-coupling reactions. Chloride and fluoride residues, often introduced during earlier synthetic steps or workup phases, bind irreversibly to Pd(0) active sites, drastically reducing turnover numbers and extending reaction times. Our purification protocols are optimized to minimize these contaminants, delivering material that maintains catalyst longevity in sensitive transition-metal systems. We provide a comprehensive COA with every shipment, allowing R&D and procurement teams to verify batch consistency before reactor charging.
Below is a comparative overview of our available purity grades. Exact numerical thresholds are batch-dependent and must be verified against the accompanying documentation.
| Parameter | Standard Grade | High Purity Grade | Pharmaceutical Grade |
|---|---|---|---|
| Assay (HPLC) | Please refer to the batch-specific COA | Please refer to the batch-specific COA | Please refer to the batch-specific COA |
| Residual Solvents (ICH Q3C) | Please refer to the batch-specific COA | Please refer to the batch-specific COA | Please refer to the batch-specific COA |
| Trace Halide Content (ppm) | Please refer to the batch-specific COA | Please refer to the batch-specific COA | Please refer to the batch-specific COA |
| Particle Size D50 (µm) | Please refer to the batch-specific COA | Please refer to the batch-specific COA | Please refer to the batch-specific COA |
Teams transitioning from other global manufacturers will find our industrial purity specifications align directly with existing process parameters. This drop-in compatibility eliminates the need for protocol revalidation while reducing procurement costs and mitigating supply chain volatility.
Technical Specs & Bulk Packaging Validation for 5-(4-Fluorophenyl)-5-oxopentanoic Acid in PPAR Triple Activator Pipelines
Developing PPAR triple activators requires intermediates that maintain structural integrity under diverse reaction conditions. Solubility anomalies in fluorinated intermediates often stem from inconsistent crystal habits or uncontrolled impurity profiles, both of which disrupt ligand binding assays and downstream purification. Our 5-(4-Fluorophenyl)-5-oxopentanoic acid, also referenced in literature as 4-(4-Fluorobenzoyl)butyric acid or 5-(4-Fluorophenyl)-5-oxovaleric Acid, is manufactured to support high-throughput medicinal chemistry and process development workflows. For teams evaluating alternative nomenclature, 4-fluoro-delta-oxo-benzenepentanoic acid describes the identical molecular architecture.
Bulk packaging validation ensures that tonnage shipments maintain the same physical and chemical properties as laboratory-scale samples. We utilize sealed IBC containers and 210L drums with desiccant packs to preserve material stability during ocean or air freight. Transit routing is optimized to minimize temperature fluctuations, and all shipments include handling instructions focused on mechanical protection and moisture exclusion. For researchers navigating complex fluorophenyl ketone transformations, reviewing our technical guidance on managing side-chain reduction impurities in fluorophenyl ketones provides additional context on maintaining selectivity during multi-step sequences. Detailed technical documentation for this Ezetimibe intermediate is available at our 5-(4-Fluorophenyl)-5-oxopentanoic acid technical data sheet.
Frequently Asked Questions
What solvent systems yield the highest coupling efficiency for this intermediate?
Polar aprotic solvents such as anhydrous DMF, NMP, or DMSO provide the highest coupling efficiency due to their ability to stabilize activated ester intermediates and promote rapid nucleophilic attack. Non-polar solvents require elevated temperatures or co-solvent systems, which can introduce thermal degradation risks. Maintaining strict moisture control and inert atmosphere conditions is critical to preventing hydrolysis and N-acylurea formation.
What particle size distribution is required to maintain consistent reaction kinetics in large-scale batches?
A controlled D50 range with minimal D90 deviation is required to ensure uniform dissolution rates and prevent localized supersaturation. Micronized grades reduce diffusion layer thickness, accelerating mass transfer in heterogeneous mixtures. Consistent particle size distribution eliminates feed rate variability during automated dosing and prevents exothermic spikes caused by rapid dissolution of fine fractions.
What are the compatibility thresholds for sensitive transition-metal catalyzed steps?
Trace halide content must remain below catalyst tolerance limits to prevent irreversible binding to palladium or nickel active sites. Elevated chloride or fluoride levels reduce turnover numbers, extend reaction times, and increase ligand degradation. Our purification protocols minimize these impurities, ensuring material compatibility with sensitive cross-coupling and hydrogenation sequences without requiring catalyst overloading or extended reaction cycles.
Sourcing and Technical Support
NINGBO INNO PHARMCHEM CO.,LTD. provides engineered fluorinated intermediates designed for seamless integration into existing medicinal chemistry and process development workflows. Our manufacturing protocols prioritize batch consistency, impurity control, and reliable bulk logistics to support uninterrupted pipeline progression. Technical documentation, handling guidelines, and tonnage availability are managed directly by our engineering and logistics teams to ensure precise alignment with your operational requirements. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.